Top Markets
Coin of the day
Cybin Inc. Common Stock Cybin Inc. Common Stock

Cybin Inc. Common Stock

HELP
Rang in aandelen #11953
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Aandeelprijs
$10.30
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$638.32M
Verandering (1 dag)
2.88%
Verandering (1 jaar)
-
Land
CA
Handel Cybin Inc. Common Stock (HELP)

Categorie

Koersgeschiedenis voor Cybin Inc. Common Stock (HELP)
Hoogste slotkoers: $10.75 op 2026-08-01

Laagste slotkoers: $7.16 op 2025-12-01
Koersgeschiedenis van Cybin Inc. Common Stock van 2025 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -13.74%
2025 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.36 -12.82%
AU
$138.18 473.58%
US
$759.27 7.20%
CH